ClinicalTrials.gg
RecruitingNCT07186023PredictNPIUpdated Nov 16, 2026

Effects of Mindfulness or Brain Stimulation Intervention for Late-life Adults in Taiwan Urban and Rural Areas

An interventional study of MBSR and MBWC in Late-Life Adults, Late-Life Prodromal Depression and Late-Life Depression, sponsored by National Health Research Institutes, Taiwan. Recruiting at 2 sites in Taiwan. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by National Health Research Institutes, Taiwan · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
124
Allocation
Non-randomized
Ages
55 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 166 studies in Depression with a site in Taiwan — 36 open to participants now, 43 under way, 3 of them phase 3. Depression · Taiwan.

Planned enrollment
36th of 141
124 · median 80
Started
2025
with 15 others
No phase
118 of 166
29 open now
Primary completion
2028-05
later than 35 of 42 live
Registered
133rd of 166
by date

Among the 166 studies in Depression with a site in Taiwan, this one is the 36th largest by planned enrollment of the 141 interventional ones that give a count, is one of 16 that started in 2025, is one of 118 with no phase, reaches primary completion later than 35 of the 42 other live ones, and was the 133rd registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

36 of the 166 studies in Depression with a site in Taiwan are open now. Recruiting first, the newest first:

30 more — sign in →

All 36 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 55 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 166 studies in Depression with a site in Taiwan, or all of them as a file.
02

Study summary

This randomized controlled trial will examine the effects of mindfulness-based interventions and brain stimulation interventions on cognitive function and psychological well-being in older adults. The study will employ a comprehensive assessment approach incorporating psychological evaluations, behavioral assessments, psychophysiological measurements, and neuroimaging analyses to characterize the outcome of nonpharmaceutical interventions in improving geriatric well-being or reducing depression severity.

03

Conditions studied

  • Late-Life Adults
  • Late-Life Prodromal Depression
  • Late-Life Depression
  • Mindfulness
  • Brain Stimulation Intervention

Browse trials for

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria for individuals participating in mindfulness-based Interventions:

  • Literate or have received an education above the elementary level.
  • Have normal or corrected vision and hearing, able to communicate and understand explanations.
  • Right-handed individuals as assessed by the Edinburgh Handedness Inventory.

Exclusion Criteria for individuals participating in mindfulness-based Interventions:

  • Individuals with dementia, stroke, cerebrovascular disease, brain injury, epilepsy, or Parkinson's disease.
  • Individuals with neurological system disorders.
  • Individuals with alcohol or drug dependence.
  • Individuals with other major physical illnesses, such as diabetes, heart failure, or endocrine abnormalities, or those who have experienced an acute myocardial infarction within the past three months.
  • Individuals with metal objects in the body that cannot undergo magnetic resonance imaging (MRI), such as cardiac pacemakers, vascular clips, hearing aids, artificial joints, steel pins, etc.
  • Individuals with Claustrophobia.
  • Individuals in pregnancy or possibility of pregnancy.

Inclusion Criteria for individuals participating in brain stimulation Intervention:

  • Individuals diagnosed with major depressive disorder by psychiatrists according to the Diagnostic and Statistical Manual, and who can cooperate with the psychiatric outpatient clinic regulations.
  • Literate or have received an education above the elementary level.
  • Have normal or corrected vision and hearing, able to communicate and understand explanations.
  • Right-handed individuals as assessed by the Edinburgh Handedness Inventory.
  • Individuals are prescribed brain stimulation therapy by clinical physicians.

Exclusion Criteria for individuals participating in brain stimulation Intervention:

  • Individuals with dementia, stroke, cerebrovascular disease, brain injury, epilepsy, or Parkinson's disease.
  • Individuals with neurological system disorders.
  • Individuals with alcohol or drug dependence.
  • Individuals with other major physical illnesses, such as diabetes, heart failure, or endocrine abnormalities, or those who have experienced an acute myocardial infarction within the past three months.
  • Individuals with metal objects in the body that cannot undergo magnetic resonance imaging (MRI), such as cardiac pacemakers, vascular clips, hearing aids, artificial joints, steel pins, etc.
  • Individuals with Claustrophobia.
  • Individuals in pregnancy or possibility of pregnancy.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
124 participants (estimated)

Study arms

  • Active comparator
    MBSR

    Mindfulness-Based Stress Reduction

    Behavioral: MBSR

  • Active comparator
    MBWC

    Mindfulness-Based Well-Being Curriculum

    Behavioral: MBWC

  • Active comparator
    MBCI

    Mindfulness-Based Curriculum for Insomnia

    Behavioral: MBCI

  • Other
    BSI

    Brain Stimulation Intervention

    Device: BSI

Interventions

  • BehavioralMBSR

    Mindfulness-Based Stress Reduction

  • BehavioralMBWC

    Mindfulness-Based Well-Being Curriculum

  • BehavioralMBCI

    Mindfulness-Based Curriculum for Insomnia

  • DeviceBSI

    Brain Stimulation Intervention

06

What researchers measure

Primary outcomes

  1. Changes in neural activation related to emotional processing, sensory processing, attention, and memory-related brain regions.

    Significant alterations in blood oxygen level-dependent (BOLD) signal amplitude during task-based functional magnetic resonance imaging (fMRI).

    Time frame: Baseline assessment conducted during the 4-week period prior to intervention initiation; follow-up assessment conducted during the 4-week period following intervention completion.

  2. Changes in resting-state functional connectivity within and between brain networks

    Statistically significant alterations in intrinsic functional connectivity parameters derived from blood-oxygen-level-dependent (BOLD) signals acquired during resting-state functional magnetic resonance imaging (rs-fMRI).

    Time frame: Baseline assessment conducted during the 4-week period prior to intervention initiation; follow-up assessment conducted during the 4-week period following intervention completion.

Secondary outcomes

  1. Regional brain morphometric changes, assessed by quantitative analysis of gray matter volume, thickness, and density differences using high-resolution structural magnetic resonance imaging.

    Statistically significant alterations in regional gray matter volume (measured in cubic millimeters), thickness (measured in millimeters) or density (represented as a percentage between 0 and 1) compared to baseline measurements.

    Time frame: Baseline assessment conducted during the 4-week period prior to intervention initiation; follow-up assessment conducted during the 4-week period following intervention completion.

  2. Self-reported neuropsychological outcomes assessed through validated Wechsler Adult Intelligence Scale (WAIS).

    Statistically significant changes across 3 time points using WAIS across subsets of facial memory test and (scores between 0 and 48), digit span in forward (scores between 0 and 16) and backward order (scores between 0 and 14), block design (scores between 0 and 68), digit symbol-coding (scores between 0 and 133).

    Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  3. Scores of the total number of category-naming items correctly named within one minute for testing verbal fluency.

    Statistically significant changes across 3 time points using Verbal fluency scores in categories of colors, animals, cities, and fruits.

    Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  4. Changes in the depression scale

    Depression scale changes measured by the geriatric depression scale (scores between 0 and 15) and the 17-item Hamilton depression rating scale (scores between 0 and 52) across 3 time points.

    Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  5. Changes in anxiety scale

    Anxiety scale changes measured by the Hamilton anxiety rating scale (scores between 0 and 48) across 3 time points.

    Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  6. Changes in the loneliness scale

    Changes of the loneliness scale developed by the University of California, Los Angeles, across 3 time points

    Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  7. Changes in perceived stress

    Changes of the 14-item perceived stress scale (scores between 0 and 56) across 3 time points

    Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  8. Changes in the apathy scale

    Changes of the 18-item apathy evaluation scale (scores between 0 and 72) across 3 time points

    Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  9. Changes in self-reported sleep outcomes assessed through sleepiness and sleep quality

    Changes of the 3-item insomnia severity index for sleepiness (scores between 0 and 28) and the 10-item Pittsburgh Sleep Quality Index for sleep quality across 3 time points

    Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  10. Changes in self-reported intervention outcomes in terms of mindfulness, flourishing, and well-being

    Changes of Intervention outcomes assessed by the 39-item five-facet mindfulness questionnaire, 30-item flourishing scale across 5 domains (mercifulness, playfulness, respectfulness, peacefulness, healthfulness), and two forms of well-being scale (short and long forms) across 3 time points. The short form is the World Health Organization-five well-being index (scores between 0 and 25). The long form is a 29-item well-being scale for the elderly in Taiwan (scores between 0 and 145).

    Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).

  11. Dynamic patterns of objective sleep parameters assessed through smart watch monitoring

    Dynamic patterns of sleep indices (including sleep stage duration, sleep onset latency, and sleep efficiency), measured by a smart watch from baseline through to 1-month follow-up assessments.

    Time frame: Continuous physiological monitoring conducted from 4 weeks pre-intervention through 4 weeks post-completion of the 1-month follow-up period (total monitoring duration: 16 weeks).

  12. Dynamic patterns of objective cardiovascular parameters assessed through smart watch monitoring

    Dynamic patterns of indices deriving from heart rate (including heart rate variability and stress), measured by a smart watch, from baseline through to 1-month follow-up assessments.

    Time frame: Continuous physiological monitoring conducted from 4 weeks pre-intervention through 4 weeks post-completion of the 1-month follow-up period (total monitoring duration: 16 weeks).

07

Study locations

1 of 2 sites recruiting
  • Shuang Ho Biomedical Park, Taipei Medical University
    New Taipei City, 235603, Taiwan
    Recruiting
  • National Center for Geriatrics and Welfare Research
    Yunlin, 632007, Taiwan
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for May 2028, 33 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 33 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 14, 2025
First posted
Sep 22, 2025
StartActual
Aug 1, 2025
Primary completionEst.
May 2028
CompletionEst.
Dec 2028
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07186023
Responsible party
Ai-Ling Hsu (Assistant Investigator, National Health Research Institutes, Taiwan) — Principal investigator
First posted
Sep 22, 2025
Start date
Aug 1, 2025
Primary completion
May 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Nov 16, 2026

Study contacts

Ai-Ling Hsu, PhD.
Contact
alhsu@nhri.edu.tw
+886-5-6327369 ext. 143
Changwei W. Wu, PhD.
Contact
sleepbrain@tmu.edu.tw
+886-2-66202589 ext. 10518

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion